The Medline Inc. (MDLN) SEC filings page on Stock Titan is designed to help investors and researchers review the company’s regulatory disclosures as it becomes and operates as a publicly traded company. Medline has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to an initial public offering of its common stock, and it has announced the effectiveness of that registration statement and the pricing and closing of an upsized initial public offering of Class A common stock on the Nasdaq Global Select Market.
As Medline continues to report as a public company, this page will surface filings such as registration statements, annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, when available. These documents are where Medline provides detailed information about its med-surg products and supply chain solutions, its two operating segments (Medline Brand and Supply Chain Solutions), its revenue sources, risk factors and other material business information.
Stock Titan enhances access to these filings with AI-powered summaries that explain the key points of lengthy documents in plain language. Instead of reading an entire registration statement or future 10-K, users can rely on AI-generated highlights that point to major business updates, capital structure changes, and disclosures related to Medline’s role as what it describes as the largest provider of med-surg products and supply chain solutions serving all points of care, based on total net sales of med-surg products.
The filings page also connects users to real-time updates from the SEC’s EDGAR system as new Medline filings are posted. Over time, this includes information on executive and insider transactions reported on Form 4, as well as proxy statements that describe governance and compensation matters. Together, these tools allow users to follow MDLN’s regulatory history and understand how Medline presents its business and risks in official SEC documents.
Medline Inc. insider filing shows large Carlyle-affiliated ownership stakes. A group of Carlyle-related entities reports indirect beneficial ownership of 111,994,953 shares of Medline’s Class A common stock and 55,557,381 shares of Class B common stock as of the event date. They also hold 55,557,381 Common Units of Medline Holdings, LP, each paired with a corresponding share of Class B stock.
Class B shares carry one vote per share but have no economic value. Under an exchange agreement dated December 16, 2025, holders can exchange their Common Units for Class A common stock on a one-for-one basis, with customary adjustments for stock splits and dividends, and the related Class B shares are automatically cancelled on exchange. The filing reflects indirect holdings through a series of CP Circle ML Holdco limited partnerships managed within the Carlyle structure.
Medline Inc. insider filing shows large Carlyle-affiliated ownership. On 01/16/2026, a group of CP Circle ML investment vehicles associated with The Carlyle Group reported indirect beneficial ownership of 111,994,953 shares of Class A Common Stock and 55,557,381 shares of Class B Common Stock, as well as 55,557,381 Common Units of Medline Holdings, LP. The Class B shares carry one vote per share but no economic value and are paired one-for-one with Common Units, with the Class B shares automatically cancelled when the units are exchanged into Class A stock. An exchange agreement dated December 16, 2025 gives holders the right to swap Common Units for Class A shares on a one-for-one basis, with these exchange rights not expiring.
Medline Inc. (MDLN) director Stephen H. Wise filed an initial Form 3 beneficial ownership report following an event dated 12/17/2025. In this filing, he indicates that no Medline securities are beneficially owned, and both the non-derivative and derivative securities tables show no holdings. The form is filed by one reporting person in his capacity as a director, providing a baseline disclosure of his current ownership status.
Medline Inc. director Robert R. Schmidt filed an initial insider ownership report in connection with an event dated 12/17/2025. This filing states that he currently has no securities beneficially owned in Medline Inc., meaning he does not report owning any Medline common stock or derivative securities at this time. The form is filed by a single reporting person and reflects his status solely as a director, not as an officer or 10% owner.